Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

Novo Nordisk's Wegovy launch in China begins in Shanghai at $194 per four-injection pack, significantly cheaper than U.S.

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

减重药物Ozempic的升级版 ...

After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.